• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Maricann Acquires Drug Delivery and Extraction Company

    Bryan Mc Govern
    Aug. 23, 2017 04:00PM PST
    Cannabis Investing News
    Cannabis Investing

    Maricann Group has further solidified its stance into the biotech business of cannabis by completing the acquisition of NanoLeaf Technologies.

    Maricann Group (CSE:MARI) has further solidified its stance into the biotech business of cannabis by completing (August 22) the acquisition of NanoLeaf Technologies, a company which has worked on a cannabinoid standardized dose soft gel capsule in Vesisorb a nano-dispersed drug.
    “The acquisition… will significantly enhance Maricann’s growth trajectory by expanding our product portfolio, delivering access to new markets, and strengthening our pipeline of future products,” Ben Ward, CEO of Maricann said. The acquisition is expected to be done by the end of September.
    Through this acquisition, Maricann wants to get closer to solving a challenge currently ailing the cannabis industry: “finding a predictable delivery mechanism of cannabinoids in an oral dosing format.”

    Cannabinoids are a fat-soluble compound that have low solubility, leading to low dissolution rates and significant first-pass liver metabolism resulting in low and unpredictable oral cannabinoid bioavailability. This poor solubility not only gives low oral bio-availability but also leads to high inter- and intra-subject variability and lack of dose proportionality.


    NanoLeaf focused on the extraction of tetrahydrocannabinol (THC) and cannabinoids. As part of the acquisition, Maricann will gain access to NanoLeaf’s exclusive market rights for both their extraction and drug delivery technology.
    Maricann also gets a brand new portfolio of patents commercialized globally through various markets like pharmaceuticals and cosmetics.
    Recently Maricann announced it would be raising $35 million as part of a private placement.

    Maricann gets new tech

    NanoLeaf’s drug delivery technology, VESIsorb boosts the bioavailability of cannabinoid oil, according to the company, by 600 percent.
    The company indicated their technology can provide results in various forms like soft gels, liquid capsules, lotions, sprays, drinks and water soluble powder. Potentially opening the door for Maricann to explore distinct cannabinoid delivery methods.
    Maricann began trading on April 24 of this year following its inception four years before.
    The company has steadily been building its collection of licenses from Health Canada since 2014 when it first obtained a cultivation license. In September of last year, Maricann obtained its license for the sale of cannabis extracts.

    Investor Takeaway

    Thanks to this acquisition Maricann has obtained a fascinating technology they hope will lead to new drug delivery methods for cannabis as the medical market in Canada continues to grow and the demand only gets bigger.
    On Wednesday, August 23, Maricann saw a 0.74 percent decline to its stock. After market close, the company’s shares were priced at $1.35.
    Don’t forget to follow us @INN_Cannabis for real-time news updates!
    Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

    cannabis investingdrug deliverycanadadrug delivery technology
    The Conversation (0)

    Go Deeper

    AI Powered
    CSE Marijuana Stocks

    CSE Marijuana Stocks

    Cannabis Investment: Canadian Cannabis Stocks

    Cannabis Investment: Canadian Cannabis Stocks

    Latest News

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    The Tinley Beverage Company

    BKTS:CC

    extractX

    Hygrovest Limited

    HGV:AU

    Lords & Company Worldwide Holdings

    LRDS:CNX
    Lords & Company Worldwide Holdings Logo

    Adastra Holdings

    XTRX:CNX

    MMJ Group Holdings

    MMJ:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES